Clinical Trial

Comparative Effects of Laser and Extracorpeal Shock Wave in Patients With Achilles Tendinopathy.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 7, 2025 (before its estimated September 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Achilles tendinopathy is a prevalent condition characterized by pain, swelling, and impaired function of the Achilles tendon, commonly affecting athletes and active individuals. The disorder arises from a failed healing response, leading to degenerative changes in the tendon without significant inflammation. It is categorized into insertional (at the calcaneus-Achilles junction) and non-insertional (2-6 cm proximal to the insertion) types. Intrinsic risk factors include biomechanical abnormalities and systemic conditions like diabetes and hypertension, while extrinsic factors involve excessive mechanical load and training errors. Effective management of Achilles tendinopathy is crucial for preventing long-term disability and ensuring the continuation of physical activities.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-15.
Trial Details
NCT Number NCT06986759
Lead Sponsor Riphah International University
Conditions Achilles Tendinopathy
Enrollment 44 participants
Start Date 2025-07-24
Primary Completion 2025-09-20 (estimated)
Study Completion 2025-10-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-07